Elite Pharmaceuticals Inc. | Balance Sheet
Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
6,941.80
7,464.20
11,512.20
10,594.70
7,179.20
2,277.60
Total Accounts Receivable
732.10
1,446.40
1,530.30
934.10
675.90
1,321.80
Inventories
1,932.50
3,032.00
3,293.70
6,416.00
4,898.00
4,515.70
Other Current Assets
318.40
388.10
377.80
468.00
949.30
741.40
Total Current Assets
9,924.80
12,330.70
16,714.00
18,412.70
13,702.40
8,856.50
Net Property, Plant & Equipment
4,199.60
6,401.80
8,110.70
9,039.40
8,993.70
8,443.80
Total Investments and Advances
3,594.40
389.00
389.00
389.10
391.60
398.10
Intangible Assets
6,349.90
6,381.80
6,411.80
6,419.10
7,713.00
6,634
Other Assets
249.10
417.10
48.70
50.90
81.90
69.40
Total Assets
24,317.70
25,920.30
31,674.10
34,311.10
30,882.60
24,401.90
ST Debt & Current Portion LT Debt
3,932.60
1,058.20
1,267.10
487.00
654.70
Accounts Payable
2,214.90
3,383.50
1,804.40
1,049.80
1,658.10
Other Current Liabilities
13.30
627.30
1,568.70
1,808.00
2,801.90
Total Current Liabilities
6,160.80
5,069.10
4,640.20
3,344.70
5,114.70
Long-Term Debt
60,981.60
2,065.00
2,175.60
2,161.60
3,331.20
Provision for Risks & Charges
-
-
-
-
31.40
Other Liabilities
38,373.50
18,517.30
13,694.90
3,140.80
3,929.80
Total Liabilities
105,515.90
25,651.40
20,510.70
8,647.10
12,407.10
Common Equity (Total)
81,198.20
34,731.10
33,122.20
25,664.00
4,571.60
Total Shareholders' Equity
81,198.20
268.90
11,163.50
25,664.00
18,475.50
Total Equity
81,198.20
268.90
11,163.50
25,664.00
18,475.50
Liabilities & Shareholders' Equity
24,317.70
25,920.30
31,674.10
34,311.10
30,882.60
Preferred Stock (Carrying Value)
-
35,000.00
44,285.70
-
13,904.00
About Elite Pharmaceuticals
View Profile
